Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $35,388 | 22 | 66.7% |
| Food and Beverage | $17,074 | 865 | 32.2% |
| Education | $365.63 | 9 | 0.7% |
| Travel and Lodging | $218.43 | 5 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $25,277 | 170 | $0 (2024) |
| GlaxoSmithKline, LLC. | $14,185 | 32 | $0 (2024) |
| ABBVIE INC. | $3,769 | 148 | $0 (2024) |
| UCB, Inc. | $1,607 | 94 | $0 (2024) |
| Lilly USA, LLC | $1,005 | 67 | $0 (2024) |
| Janssen Biotech, Inc. | $870.31 | 42 | $0 (2024) |
| PFIZER INC. | $861.46 | 100 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $622.84 | 33 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $611.33 | 6 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $575.90 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,104 | 152 | ABBVIE INC. ($499.42) |
| 2023 | $3,605 | 185 | AbbVie Inc. ($1,170) |
| 2022 | $21,085 | 101 | Amgen Inc. ($14,633) |
| 2021 | $13,585 | 26 | Amgen Inc. ($7,106) |
| 2020 | $4,525 | 9 | GlaxoSmithKline, LLC. ($3,079) |
| 2019 | $800.85 | 19 | Lilly USA, LLC ($300.16) |
| 2018 | $3,297 | 195 | Amgen Inc. ($797.83) |
| 2017 | $3,045 | 214 | Amgen Inc. ($535.41) |
All Payment Transactions
901 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: IMMUNOLOGY | ||||||
| 12/23/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Immunology | ||||||
| 12/20/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $4.85 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/19/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $9.21 | General |
| Category: Inflammation | ||||||
| 12/18/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $5.60 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.14 | General |
| Category: Immunology | ||||||
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $2.54 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.93 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $95.97 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: Immunology | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.24 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $6.83 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: IMMUNOLOGY | ||||||
| 11/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: Inflammation | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.28 | General |
| Category: Immunology | ||||||
| 11/25/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/21/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.98 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/14/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $98.66 | General |
| Category: Immunology | ||||||
| 11/14/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.02 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 1,285 | 34,379 | $912,316 | $270,151 |
| 2022 | 4 | 423 | 688 | $82,248 | $41,821 |
| 2021 | 3 | 460 | 842 | $97,401 | $50,139 |
| 2020 | 5 | 492 | 818 | $92,736 | $39,119 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 31 | 15,600 | $234,000 | $60,398 | 25.8% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 19 | 1,675 | $150,750 | $56,281 | 37.3% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2023 | 11 | 10,240 | $113,680 | $48,473 | 42.6% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 15 | 4,700 | $235,000 | $48,349 | 20.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 114 | 114 | $36,480 | $12,325 | 33.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 73 | 132 | $33,000 | $12,190 | 36.9% |
| 86235 | Measurement of antibody for assessment of autoimmune disorder, any method | Office | 2023 | 44 | 308 | $16,940 | $5,135 | 30.3% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 31 | 51 | $25,500 | $4,621 | 18.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 53 | 53 | $11,395 | $3,656 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 51 | $8,925 | $3,348 | 37.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 29 | 43 | $5,590 | $1,957 | 35.0% |
| 73120 | X-ray of hand, 2 views | Office | 2023 | 47 | 157 | $5,289 | $1,911 | 36.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 118 | 195 | $2,340 | $1,622 | 69.3% |
| 86480 | Tuberculosis test, gamma interferon | Office | 2023 | 20 | 20 | $3,000 | $1,215 | 40.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 62 | 119 | $3,570 | $1,207 | 33.8% |
| 83516 | Analysis of substance using immunoassay technique, multiple step method | Office | 2023 | 41 | 84 | $2,520 | $949.20 | 37.7% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 22 | 77 | $2,685 | $946.62 | 35.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 58 | 111 | $2,775 | $832.34 | 30.0% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 93 | 157 | $2,826 | $792.48 | 28.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 31 | 75 | $2,625 | $780.40 | 29.7% |
| 86200 | Measurement of antibody for rheumatoid arthritis assessment | Office | 2023 | 51 | 52 | $2,340 | $651.88 | 27.9% |
| 86225 | Measurement of dna antibody, native or double stranded | Office | 2023 | 44 | 44 | $2,200 | $562.36 | 25.6% |
| 86226 | Measurement of dna antibody, single stranded | Office | 2023 | 44 | 44 | $1,980 | $495.57 | 25.0% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2023 | 90 | 155 | $1,550 | $408.10 | 26.3% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 11 | 20 | $3,000 | $365.94 | 12.2% |
About Dr. Julio Bravo, M.D
Dr. Julio Bravo, M.D is a Specialist healthcare provider based in Winston Salem, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598739823.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Julio Bravo, M.D has received a total of $53,046 in payments from pharmaceutical and medical device companies, with $3,104 received in 2024. These payments were reported across 901 transactions from 38 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($35,388).
As a Medicare-enrolled provider, Bravo has provided services to 2,660 Medicare beneficiaries, totaling 36,727 services with total Medicare billing of $401,229. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Rheumatology, Rheumatology
- Location Winston Salem, NC
- Active Since 02/14/2006
- Last Updated 02/29/2024
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1598739823
Products in Payments
- Enbrel (Biological) $24,704
- BENLYSTA (Biological) $14,106
- RINVOQ (Biological) $1,744
- Cimzia (Drug) $1,403
- Humira (Biological) $995.63
- XELJANZ (Drug) $758.12
- SKYRIZI (Biological) $690.60
- TREMFYA (Drug) $636.20
- TALTZ (Drug) $616.42
- SAPHNELO (Biological) $575.90
- COSENTYX (Drug) $465.46
- SIMPONI ARIA (Biological) $447.05
- ORENCIA (Biological) $437.84
- KEVZARA SARILUMAB INJECTION (Biological) $409.49
- STELARA (Biological) $282.86
- KRYSTEXXA (Drug) $269.58
- KEVZARA (Biological) $239.09
- ACTHAR (Biological) $224.35
- LUPKYNIS (Drug) $216.64
- Bimzelx (Biological) $203.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Winston Salem
David Zhao, Md, MD
Specialist — Payments: $114,383
Dr. Mark Nelson, Md, MD
Specialist — Payments: $16,932
Mr. David Spencer, M.d, M.D
Specialist — Payments: $16,218
Basil Shah, Md, MD
Specialist — Payments: $4,692
Nada El Husseini, Md, MD
Specialist — Payments: $2,541
Dr. Thai Phan, Md, MD
Specialist — Payments: $1,559